23,424 reports of this reaction
7.9% of all MORPHINE SULFATE reports
#2 most reported adverse reaction
OVERDOSE is the #2 most commonly reported adverse reaction for MORPHINE SULFATE, manufactured by Rhodes Pharmaceuticals L.P.. There are 23,424 FDA adverse event reports linking MORPHINE SULFATE to OVERDOSE. This represents approximately 7.9% of all 294,935 adverse event reports for this drug.
MORPHINE SULFATE has an overall safety score of 92 out of 100. Patients taking MORPHINE SULFATE who experience overdose should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OVERDOSE is moderately reported among MORPHINE SULFATE users, representing a notable but not dominant share of adverse events.
In addition to overdose, the following adverse reactions have been reported for MORPHINE SULFATE:
The following drugs have also been linked to overdose in FDA adverse event reports:
OVERDOSE has been reported as an adverse event in 23,424 FDA reports for MORPHINE SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
OVERDOSE accounts for approximately 7.9% of all adverse event reports for MORPHINE SULFATE, making it one of the most commonly reported side effect.
If you experience overdose while taking MORPHINE SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.